Kyle RA - Search Results

1

Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update.

Anderson K, Ismaila N, Flynn PJ, Halabi S, Jagannath S, Ogaily MS, Omel J, Raje N, Roodman GD, Yee GC, Kyle RA. Anderson K, et al. Among authors: kyle ra. J Clin Oncol. 2018 Mar 10;36(8):812-818. doi: 10.1200/JCO.2017.76.6402. Epub 2018 Jan 17. J Clin Oncol. 2018. PMID: 29341831 Free article.

2

Multiple Myeloma: New Insights and Therapeutic Approaches.

Anderson KC, Kyle RA, Dalton WS, Landowski T, Shain K, Jove R, Hazlehurst L, Berenson J. Anderson KC, et al. Among authors: kyle ra. Hematology Am Soc Hematol Educ Program. 2000:147-165. doi: 10.1182/asheducation-2000.1.147. Hematology Am Soc Hematol Educ Program. 2000. PMID: 11701540

3

Current therapy of multiple myeloma.

Kyle RA. Kyle RA. Intern Med. 2002 Mar;41(3):175-80. doi: 10.2169/internalmedicine.41.175. Intern Med. 2002. PMID: 11929176 Free article. Review.

4

Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.

Rajkumar SV, Mesa RA, Fonseca R, Schroeder G, Plevak MF, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Gertz MA, Kyle RA, Russell SJ, Greipp PR. Rajkumar SV, et al. Among authors: kyle ra. Clin Cancer Res. 2002 Jul;8(7):2210-6. Clin Cancer Res. 2002. PMID: 12114422

5

Current therapy for multiple myeloma.

Rajkumar SV, Gertz MA, Kyle RA, Greipp PR; Mayo Clinic Myeloma, Amyloid, and Dysproteinemia Group. Rajkumar SV, et al. Among authors: kyle ra. Mayo Clin Proc. 2002 Aug;77(8):813-22. doi: 10.4065/77.8.813. Mayo Clin Proc. 2002. PMID: 12173715 Review.

6

American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.

Berenson JR, Hillner BE, Kyle RA, Anderson K, Lipton A, Yee GC, Biermann JS; American Society of Clinical Oncology Bisphosphonates Expert Panel. Berenson JR, et al. Among authors: kyle ra. J Clin Oncol. 2002 Sep 1;20(17):3719-36. doi: 10.1200/JCO.2002.06.037. J Clin Oncol. 2002. PMID: 12202673

7

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma.

Rajkumar SV, Hayman S, Gertz MA, Dispenzieri A, Lacy MQ, Greipp PR, Geyer S, Iturria N, Fonseca R, Lust JA, Kyle RA, Witzig TE. Rajkumar SV, et al. Among authors: kyle ra. J Clin Oncol. 2002 Nov 1;20(21):4319-23. doi: 10.1200/JCO.2002.02.116. J Clin Oncol. 2002. PMID: 12409330 Clinical Trial.

8

Bone marrow angiogenesis in multiple myeloma: effect of therapy.

Kumar S, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Gertz MA, Kyle RA, Greipp PR, Rajkumar SV. Kumar S, et al. Among authors: kyle ra. Br J Haematol. 2002 Dec;119(3):665-71. doi: 10.1046/j.1365-2141.2002.03871.x. Br J Haematol. 2002. PMID: 12437642 Free article.

9

Diagnosis of multiple myeloma.

Kyle RA. Kyle RA. Semin Oncol. 2002 Dec;29(6 Suppl 17):2-4. doi: 10.1053/sonc.2002.34069. Semin Oncol. 2002. PMID: 12520477

10

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review.

Hahn T, Wingard JR, Anderson KC, Bensinger WI, Berenson JR, Brozeit G, Carver JR, Kyle RA, McCarthy PL Jr. Hahn T, et al. Among authors: kyle ra. Biol Blood Marrow Transplant. 2003 Jan;9(1):4-37. doi: 10.1053/bbmt.2003.50002. Biol Blood Marrow Transplant. 2003. PMID: 12533739 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,539 results

Search Page

Filters